International Biotechnology Trust PLC Exelixis, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$15.68 - $22.27 $8.4 Million - $11.9 Million	535,710 Added 7348.56%	543,000 $8.51 Million
Q2 2022 Aug 16, 2022	BUY	$17.44 - $23.16 $127,137 - $168,836	7,290 New	7,290 $350 Million
Q4 2021 Feb 15, 2022	SELL	$15.84 - $21.88 $7.75 Million - $10.7 Million	-489,534 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $6.32 Million - $8.2 Million	388,000 Added 382.14%	489,534 $10.3 Million
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $14.1 Million - $20.1 Million	-785,000 Reduced 88.55%	101,534 $1.85 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $7.39 Million - $9.08 Million	360,000 Added 68.37%	886,534 $20 Million
Q3 2020 Dec 01, 2020	BUY	$20.67 - $26.94 $1.53 Million - $1.99 Million	74,000 Added 16.35%	526,534 $12.9 Million
Q2 2020 Jul 14, 2020	BUY	$16.46 - $27.42 $5.74 Million - $9.57 Million	349,000 Added 337.09%	452,534 $10.3 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $6.01 Million - $7.7 Million	-340,000 Reduced 76.66%	103,534 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $3.79 Million - $4.95 Million	200,000 Added 82.12%	443,534 $9.48 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $6.78 Million - $8.57 Million	-346,000 Reduced 58.69%	243,534 $5.79 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $1.57 Million - $2.51 Million	-115,000 Reduced 16.32%	589,534 $9.11 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $11 Million - $15.6 Million	694,934 Added 7238.9%	704,534 $9.57 Million
Q3 2018 Nov 13, 2018	SELL	$15.87 - $22.4 $6.9 Million - $9.74 Million	-434,934 Reduced 97.84%	9,600 $1.27 Million
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $1.04 Million - $1.26 Million	56,200 Added 14.47%	444,534 $9.57 Million
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $487,299 - $701,580	-22,000 Reduced 5.36%	388,334 $8.6 Million
Q4 2017 Mar 02, 2018	BUY	$24.23 - $30.93 $3.78 Million - $4.83 Million	156,000 Added 61.34%	410,334 $12.5 Million
Q3 2017 Mar 02, 2018	BUY	$23.35 - $29.24 $1.11 Million - $1.38 Million	47,334 Added 22.87%	254,334 $6.16 Million
Q2 2017 Mar 02, 2018	BUY	N/A	76,000 Added 58.02%	207,000 $5.1 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-54,000 Reduced 29.19%	131,000 $2.84 Million
Q4 2016 Mar 02, 2018	BUY	N/A	185,000	185,000 $2.76 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account